Glaukos Corporation

Research Glaukos Corporation (GKOS) on Bullrun: market cap USD 9.89B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 9.89B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 507.44M-USD 187.69M-USD 22.46M55.7%-3.28USD 90.81MUSD 103.88MUSD 656.16M
FY2024USD 383.48M-USD 146.37M-USD 67.62M75.5%-2.77USD 169.63MUSD 103.40MUSD 766.93M
FY2023USD 314.71M-USD 134.66M-USD 78.01M76.0%-2.78USD 93.47MUSD 383.74MUSD 461.77M
FY2022USD 282.86M-USD 99.20M-USD 63.35M75.6%-2.09USD 119.53MUSD 382.48MUSD 530.01M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-12USD 9.89Bn/an/an/a
20252025-12-31USD 6.49Bn/an/an/a
20242024-12-31USD 8.46Bn/an/an/a
20232023-12-29USD 3.88Bn/an/an/a
20222022-12-30USD 2.08Bn/an/an/a
20212021-12-31USD 2.09Bn/an/an/a

About Glaukos Corporation

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.

ETFs that hold Glaukos Corporation

Glaukos Corporation is one of the ten largest holdings of 8 ETFs that investors in Europe can buy, most traded first:

ETFWeightTER
State Street SPDR Russell 2000 US Small Cap UCITS ETF0.33%0.30%
iShares S&P SmallCap 600 UCITS ETF USD (Dist)0.56%0.30%
Xtrackers Russell 2000 UCITS ETF 1C0.33%0.30%
iShares Ageing Population UCITS ETF USD (Acc)0.66%0.40%
Amundi S&P SmallCap 600 Screened UCITS ETF DIST0.90%0.35%
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc0.33%0.20%
VanEck Medical Robotics and Bionic Engineering UCITS ETF3.75%0.55%
State Street SPDR Russell 2000 US Small Cap UCITS ETF EUR Hedged Acc0.33%0.35%

Compare every fund on the same index:

Russell 2000 ETFs

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

Abbott Laboratories (ABT) Adagio Medical Holdings Inc (ADGM) Aethlon Medical Inc (AEMD) AdaptHealth Corp (AHCO) Alamar Biosciences, Inc. (ALMR) Allurion Technologies Inc (ALUR) Autonomix Medical Inc (AMIX) Artivion Inc (AORT) AOTI Inc (AOTI) Apyx Medical Corp (APYX) Accuray Inc (ARAY) Alphatec Holdings Inc (ATEC)

Frequently asked questions

What is Glaukos Corporation's market cap?

Glaukos Corporation's market capitalization is USD 9.89B.

What does Glaukos Corporation do?

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.